Skip to search formSkip to main content

NB1011

Known as: NB 1011, NB101.1 
A novel small molecule, and a phosphoramidate derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine with antitumor property. NB1011 is selectively… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Hepatitis C virus is an infectious disease affecting millions of people worldwide and causing chronic liver disease. The current… Expand
  • figure 1.1
  • figure 1.2
  • figure 1.4
  • figure 1.5
  • figure 1.6
Is this relevant?
2005
2005
The phosphoramidate technology we have developed has been recently applied to BVdU, leading to NB1011 (NewBiotics Inc… Expand
Is this relevant?
2004
2004
3144 Background: Resistance to fluoropyrimidines (FP) is associated with increased expression of TS. N is a pronucleotide analog… Expand
Is this relevant?
2003
2003
NB1011, a phosphoramidate derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine, is a novel anti-cancer agent that selectively… Expand
Is this relevant?
2003
2003
NB1011 [E-5-(2-bromovinyl)-2'-deoxyuridine-5'-(L-methylalaninyl)-phenylphosphoramidate], a phosphoramidate prodrug of E-5-(2… Expand
Is this relevant?
2003
2003
We have determined the kinetic parameters of human recombinant thymidylate synthase (hrTS) with its natural substrate, dUMP, and… Expand
Is this relevant?
2002
2002
NB1011, a novel anticancer agent, targets tumor cells expressing high levels of thymidylate synthase (TS). NB1011 is converted… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2002
2002
NB1011, a phosphoramidate derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine, is a novel small molecule anticancer agent. NB1011… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
The in vivo administration of enzyme-inhibiting drugs for cancer and infectious disease often results in overexpression of the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2001
2001
Tumor cell resistance to fluoropyrimidines and other inhibitors of thymidylate synthase (TS) is a serious problem often… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?